Study guide

2.4 Placental Disorders: Previa, Abruption, Vasa Previa & PAS

NCC Inpatient Obstetric Nursing RNC-OB

Track your progress as you read

Finished sections get a check mark.

1 Chapter 0: Introduction & How to Use This Guide

0.1 About the RNC-OB Credential & Exam Blueprint 0.2 How to Use This Study Guide & Clinical Learning Methodology

2 Chapter 1: Pregnancy Complications — Maternal Medical Conditions

1.1 Hypertensive Disorders of Pregnancy 1.2 HELLP Syndrome & Hepatic Disorders of Pregnancy 1.3 Diabetes Mellitus in Pregnancy 1.4 Maternal Cardiac and Respiratory Disorders 1.5 Infectious Diseases in Inpatient Obstetrics 1.6 Hematologic, Endocrine, Connective Tissue & Other Systemic Disorders

3 Chapter 2: Pregnancy Complications — Preterm Labor, Multiple Gestation, Placental & Fetal Disorders

2.1 Psychosocial Disorders, Substance Use & Environmental Exposures 2.2 Preterm Labor: Assessment, Tocolysis & Neuroprotection 2.3 Multiple Gestation: Placentation, Chorionicity & Complications 2.4 Placental Disorders: Previa, Abruption, Vasa Previa & PAS 2.5 Fetal Growth Disorders & Amniotic Fluid Complications

4 Chapter 3: Antenatal Fetal Assessment & Surveillance

3.1 Antenatal Testing Methods & Indications for Fetal Surveillance 3.2 Nonstress Test (NST), Contraction Stress Test (CST) & Biophysical Profile (BPP) 3.3 Diagnostic Prenatal Procedures (Amniocentesis, CVS, PUBS, cfDNA & Ultrasound) 3.4 Fetal Oxygenation Physiology & Acid-Base Regulation 3.5 Umbilical Cord Blood Gas Collection & Clinical Interpretation

5 Chapter 4: Fetal Assessment & Electronic Fetal Monitoring (EFM)

4.1 NICHD Electronic Fetal Monitoring Terminology & Baseline Features 4.2 FHR Decelerations, Acceleration Patterns & Uterine Activity 4.3 The NICHD Three-Tier Fetal Heart Rate Classification System 4.4 Intrauterine Resuscitation & Clinical Action Protocols 4.5 Fetal Arrhythmias, Dysrhythmias & Artifact Differentiation

6 Chapter 5: Labor & Birth Physiology — Mechanics, Cardinal Movements, Stages & Support

5.1 Physiology of Labor & Uterine Mechanics 5.2 Pelvic Anatomy, Fetal Lie, Presentation & Cardinal Movements of Labor 5.3 Stages of Labor, Cervical Dilatation Dynamics & Progression Guidelines 5.4 Intrapartum Admission Assessment, Obstetric Triage & Membrane Rupture Evaluation 5.5 Labor Support, Non-Pharmacologic Pain Management & Physiologic Birth Practices

7 Chapter 6: Labor & Birth Interventions — Cervical Ripening, Induction, Pain Management & Anesthesia

6.1 Bishop Scoring, Pre-Induction Cervical Ripening & Mechanical Methods 6.2 Oxytocin Administration, Titration Protocols & Uterine Tachysystole Management 6.3 Nonpharmacologic Comfort & Labor Pain Management Strategies 6.4 Systemic Opioid Analgesia & Inhaled Nitrous Oxide 6.5 Neuraxial Analgesia, Spinal/Epidural Complications & General Anesthesia

8 Chapter 7: Labor & Birth — Operative Deliveries, TOLAC/VBAC & Special Intrapartum Procedures

7.1 External Cephalic Version (ECV) & Malpresentation Management 7.2 Operative Vaginal Delivery: Vacuum Extraction & Forceps-Assisted Birth 7.3 Cesarean Delivery: Surgical Indications, Intraoperative Management & PACU Recovery 7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC) 7.5 Special Intrapartum Procedures: Amniotomy, Amnioinfusion, Cervical Ripening & Labor Augmentation

9 Chapter 8: Obstetric Emergencies & Critical Care

8.1 Shoulder Dystocia Management & HELPERR Protocol 8.2 Umbilical Cord Prolapse & Feto-Vascular Emergencies 8.3 Uterine Rupture & Acute Uterine Inversion 8.4 Amniotic Fluid Embolism (Anaphylactoid Syndrome of Pregnancy) 8.5 Intraamniotic Infection (Chorioamnionitis) & Maternal Sepsis

10 Chapter 9: Postpartum Physiology & Immediate Recovery Care

9.1 Postpartum Physiologic Changes & Maternal Systemic Adaptations 9.2 Fourth Stage of Labor & Immediate Recovery Care 9.3 Routine Postpartum Nursing Assessment & Clinical Care (BUBBLE-HE) 9.4 Rh Isoimmunization, Alloimmunization & Postpartum Immunizations 9.5 Postpartum Discharge Teaching, Warning Signs & Maternal Safety

11 Chapter 10: Postpartum Adaptation, Hemorrhage & Clinical Complications

10.1 Postpartum Hemorrhage: Definition, Risk Stratification, 4 Ts, QBL & Pharmacotherapy 10.2 Postpartum Infections: Endometritis, Wound Infections, Sepsis & Postpartum Pyrexia 10.3 Thromboembolic Disorders: DVT, Pulmonary Embolism & Septic Pelvic Thrombophlebitis 10.4 Perinatal Mood & Anxiety Disorders: Postpartum Blues, PPD, Anxiety & Postpartum Psychosis 10.5 Lactation Physiology, Breastfeeding Complications, Engorgement & Medication Safety

12 Chapter 11: Newborn Care, Transition & Clinical Assessment

11.1 Neonatal Physiologic Transition & Cardiorespiratory Adaptation 11.2 Immediate Newborn Care, Apgar Scoring & Delivery Room Stabilization 11.3 Newborn Thermoregulation & Pathophysiology of Cold Stress 11.4 Gestational Age & Neonatal Growth Assessment 11.5 Comprehensive Newborn Head-to-Toe Examination & Normal Variants

13 Chapter 12: Newborn Complications, Resuscitation & High-Acuity Management

12.1 Neonatal Resuscitation Program (NRP 8th Edition) & Delivery Room Resuscitation 12.2 Neonatal Glucose Homeostasis, Hypoglycemia Screening & Clinical Management 12.3 Neonatal Hyperbilirubinemia, Bilirubin Metabolism & Phototherapy Protocols 12.4 Neonatal Respiratory Distress: TTN, RDS, Meconium Aspiration & Persistent Pulmonary Hypertension (PPHN) 12.5 Neonatal Sepsis, Congenital Infections & Neonatal Abstinence Syndrome (NAS/NOWS)

14 Chapter 13: Professional Practice, Legal-Ethical Frameworks, Patient Safety & Quality Improvement

13.1 Legal Aspects of Perinatal Nursing & High-Risk Documentation Standards 13.2 Ethical Principles in Perinatal Care & Maternal-Fetal Conflicts 13.3 Quality Improvement, Perinatal Safety Initiatives & AIM Bundles 13.4 Patient Safety Culture, Team Communication & Clinical Escalation 13.5 Evidence-Based Practice, Research Utilization & Perinatal Guidelines

2.4 Placental Disorders: Previa, Abruption, Vasa Previa & PAS

Key Takeaways Explain This Topic AI

Digital vaginal examination is strictly contraindicated in the presence of third-trimester vaginal bleeding until placenta previa and vasa previa are definitively ruled out by ultrasound imaging.

Placenta previa classically presents with painless, bright red vaginal bleeding and a soft, non-tender uterus; scheduled cesarean delivery is recommended at 36 0/7 to 37 6/7 weeks.

Placental abruption presents with painful dark red bleeding (or concealed hemorrhage), severe uterine hypertonicity ('woody' abdomen), frequent contractions, late decelerations, and risk of DIC (fibrinogen <200 mg/dL is a critical marker of consumption).

Vasa previa presents with sudden painless vaginal bleeding at the exact moment of membrane rupture accompanied by catastrophic fetal bradycardia/exsanguination; prenatally diagnosed cases require scheduled cesarean delivery at 34 0/7 to 35 6/7 weeks.

Placenta Accreta Spectrum (PAS) with prior cesarean delivery and current previa requires multidisciplinary surgical planning for scheduled cesarean hysterectomy at 34 0/7 to 35 6/7 weeks without attempting manual placental separation.

Last updated: August 2026

Comparative Overview of Obstetric Placental Disorders

Third-trimester vaginal bleeding is an obstetric emergency requiring immediate, methodical clinical assessment. The labor and delivery nurse must rapidly differentiate between maternal bleeding disorders (placenta previa, placental abruption, placenta accreta spectrum) and fetal bleeding disorders (vasa previa) to prevent catastrophic maternal-fetal morbidity. [ THIRD-TRIMESTER VAGINAL BLEEDING TRIAGE ]

  • │
  • ┌──────────────────────────────┴──────────────────────────────┐
  • ▼ ▼
  • [ PAINLESS Bright Red Bleeding ] [ PAINFUL Dark Red Bleeding ]
  • Soft, relaxed, non-tender uterus • Rigid, hypertonic "woody" uterus
  • Normal baseline resting tone • High baseline tone, tachysystole
  • FHR usually reassuring initially • Recurrent late decels, bradycardia
  • │ │
  • ┌───────┴───────┐ ▼
  • ▼ ▼ [ PLACENTAL ABRUPTION ]
  • [ PLACENTA PREVIA ] [ VASA PREVIA ] • Check Fibrinogen / DIC
  • NO DIGITAL EXAM! • Occurs at ROM • 2 large-bore IV lines
  • Confirm via US • Immediate Fetal • MTP readiness
  • Plan C/S at 36–37w Bradycardia / Exsanguination • Urgent delivery if compromised
  • 1. Placenta Previa

Definition & Classifications: Placental tissue implants over or adjacent to the internal cervical os in the lower uterine segment:

Complete Previa: The placenta completely covers the internal cervical os.

Marginal Previa: The placental edge extends to within <2.0 cm of the internal cervical os but does not cover it.

Low-Lying Placenta: The placental edge is located 2.0 to 3.5 cm from the internal cervical os.

Pathophysiology & "Migration": In early pregnancy, up to 4% of gestations exhibit a low-lying placenta. Due to differential growth and elongation of the muscular lower uterine segment in the late second and third trimesters, >90% of early previas "migrate" away from the cervix (trophotropism) by term.

Risk Factors: Prior cesarean delivery (scar tissue impairs fundal implantation), prior uterine curettage/myomectomy, multiparity, advanced maternal age ( ≥ 35 years \ge 35\text{ years} ≥ 35 years ), cigarette smoking, cocaine use, multifetal gestation (larger placental surface area), and prior placenta previa (4- to 8-fold increased recurrence).

Clinical Presentation: Classic hallmark is PAINLESS, bright red vaginal bleeding in the second or third trimester. The uterus remains soft, non-tender, and relaxed with normal resting tone . Fetal heart rate is typically reassuring unless severe maternal hypovolemic shock occurs.

Management Guidelines:

STRICT CONTRAINDICATION: No digital vaginal examinations under any circumstance until ultrasound definitively confirms placental location.

Pelvic Rest: Strict avoidance of sexual intercourse, vaginal exams, and strenuous physical exertion.

Delivery Timing: Scheduled cesarean delivery is recommended at 36 0/7 to 37 6/7 weeks (or earlier if persistent bleeding or hemodynamic instability occurs).

2. Placental Abruption (Abruptio Placentae)

Definition: The premature separation of a normally implanted placenta from the uterine decidua basalis prior to the delivery of the fetus.

Classifications:

Revealed (External) Abruption (~80%): Blood dissects downward between the fetal membranes and decidua, exiting through the cervix.

Concealed (Internal) Abruption (~20%): Blood remains trapped behind the placenta (retroplacental hematoma) with no visible external bleeding. Represents the highest clinical risk because bleeding severity is masked.

Risk Factors: Maternal hypertension / preeclampsia (strongest chronic factor), sudden abdominal trauma (MVA, domestic violence), cocaine or methamphetamine use (acute vasospasm), cigarette smoking, sudden uterine decompression (rapid amniotic fluid loss in polyhydramnios or delivery of first twin), and history of prior abruption (10-fold increased risk).

Clinical Hallmark Signs:

PAINFUL, dark red vaginal bleeding (or severe pain with no visible bleeding in concealed abruption).

Severe continuous uterine/abdominal pain and back pain.

Uterine hypertonicity and board-like rigidity ("woody" abdomen) with high resting tone (>20–25 mmHg on IUPC) and frequent, low-amplitude uterine contractions (uterine tachysystole).

Fetal Distress: Recurrent late decelerations, loss of variability, severe prolonged decelerations, and fetal bradycardia.

Couvelaire Uterus: Massive retroplacental hemorrhage dissects into the myometrial smooth muscle bundles and beneath the uterine serosa, giving the uterus a dark, ecchymotic, purple/copper appearance. Severely impairs myometrial contractility, causing refractory postpartum hemorrhage due to uterine atony.

Disseminated Intravascular Coagulation (DIC): Decidual trauma releases massive quantities of tissue factor (thromboplastin) into maternal circulation, activating the extrinsic coagulation cascade. Fibrinogen, platelets, and clotting factors are rapidly consumed. A maternal serum fibrinogen level <200 mg/dL in pregnancy is abnormal (normal pregnancy fibrinogen is 400–600 mg/dL) and indicates early consumptive coagulopathy; <100–150 mg/dL reflects severe DIC.

Emergency Nursing Interventions for Abruption

Establish large-bore IV access: Two 16- or 18-gauge peripheral IV lines immediately.

Stat Laboratory Workup: Type and crossmatch (4–6 units PRBCs), CBC, PT/INR, PTT, Fibrinogen, D-dimer, and Kleihauer-Betke test.

Continuous Maternal-Fetal Surveillance: Continuous EFM and continuous maternal vital signs monitoring.

Massive Transfusion Protocol (MTP) Readiness: Prepare 1:1:1 balanced resuscitation (PRBCs, FFP, Platelets) and Cryoprecipitate (to restore fibrinogen >150–200 mg/dL).

Immediate Delivery Planning: Emergent cesarean delivery for maternal/fetal compromise, or rapid controlled vaginal delivery if fetal demise has occurred and maternal status is stabilized.

3. Vasa Previa

Pathophysiology: Fetal blood vessels traverse the fetal membranes across the internal cervical os, unsupported by either the umbilical cord Wharton's jelly or placental tissue.

Underlying Anatomical Variations:

Velamentous Cord Insertion: The umbilical cord inserts into the amniotic membranes rather than the placental mass; vessels travel through membranes to reach the placenta.

Succenturiate Placental Lobe: An accessory placental lobe connected to the main placenta by membranous fetal vessels traversing the internal os.

Clinical Presentation: PAINLESS vaginal bleeding at the EXACT MOMENT of membrane rupture (spontaneous rupture or artificial amniotomy), immediately followed by catastrophic fetal bradycardia, sinusoidal pattern, or rapid fetal exsanguination .

Critical Fact: The bleeding is 100% fetal blood . Total fetal-placental blood volume is only ~80–100 mL/kg (~250–300 mL total at term); a loss of even 50 to 100 mL can cause fatal fetal hypovolemic shock within minutes.

Management: Prenatally diagnosed vasa previa requires elective hospitalization at 30 to 34 weeks , antenatal corticosteroids, and planned scheduled cesarean delivery at 34 0/7 to 35 6/7 weeks (prior to the onset of labor or membrane rupture).

4. Placenta Accreta Spectrum (PAS)

Placenta Accreta Spectrum refers to the pathologic adherence and invasion of placental trophoblasts into the uterine myometrium due to partial or complete absence of the decidua basalis and Nitabuch's layer . [ PLACENTA ACCRETA SPECTRUM DEPTH OF INVASION ]

1. Placenta Accreta (~75%) Placenta attached directly to superficial myometrium;

no muscular invasion.

2. Placenta Increta (~15%) Chorionic villi invade deeply into myometrial muscle wall.

3. Placenta Percreta (~5–10%) Chorionic villi penetrate COMPLETELY through myometrium,

invading uterine serosa and adjacent pelvic organs (bladder).

Major Risk Factors: The combination of prior cesarean delivery AND current placenta previa creates the highest risk for PAS:

  • 1 prior CD + previa: ~11% risk
  • 2 prior CDs + previa: ~40% risk
  • 3 prior CDs + previa: ~61% risk
  • ≥ 4 \ge 4 ≥ 4 prior CDs + previa: >67% risk

Surgical Management Protocol: Multidisciplinary team in a Level III/IV perinatal center (MFM, Gynecologic Oncology, Obstetric Anesthesia, Interventional Radiology, Blood Bank). Scheduled cesarean hysterectomy at 34 0/7 to 35 6/7 weeks . DO NOT attempt manual removal of the placenta upon delivery of the fetus, as forced separation triggers catastrophic, life-threatening maternal hemorrhage.

Master Differentiation Table of Obstetric Placental Disorders

Disorder Bleeding Characteristics Uterine Tone & Pain Fetal Heart Rate Pattern Primary Maternal / Fetal Risk Delivery Timing & Mode

Placenta Previa Painless , bright red; intermittent or continuous Uterus soft, non-tender, relaxed ; normal resting tone Usually normal / reassuring initially Maternal hemorrhage; premature delivery Scheduled Cesarean at 36 0/7–37 6/7 weeks

Placental Abruption Painful , dark red (or concealed in 20%) Hypertonic, rigid ("woody") , severe constant pain, tachysystole Non-reassuring: late decelerations, loss of variability, bradycardia Maternal shock, DIC (fibrinogen <200) , fetal demise Urgent delivery (emergent C/S or rapid vaginal birth)

Vasa Previa Painless , bright red; occurs at rupture of membranes Normal resting tone; non-tender Sudden severe bradycardia, sinusoidal pattern , fetal exsanguination Rapid fetal demise (fetal blood loss); maternal status stable Scheduled Cesarean at 34 0/7–35 6/7 weeks

Placenta Accreta (PAS) Minimal antepartum bleeding unless previa present; massive hemorrhage at delivery Normal antepartum tone Usually reassuring antepartum Massive life-threatening maternal hemorrhage, bladder injury Scheduled Cesarean Hysterectomy at 34 0/7–35 6/7 weeks